1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2026 together with the Report issued by the Statutory Auditors, M/s. Krishaan ....
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 28 May 2026, 01:49 PM IST · BSE ID: cbd011ed-04e4-4d87-b443-2a9e78dafa68
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its annual financial results, proposed a Re. 0.50 dividend, and re-appointed its cost auditor.
🤖 AI Summary
- Themis Medicare Ltd. approved Audited Standalone and Consolidated Financial Results for the year ended March 31, 2026.
- Board recommended a final dividend of Re. 0.50 per equity share for FY26, aggregating to Rs. 4,60,50,060.
- M/s. R. Nanabhoy & Co. was re-appointed as the Cost Auditor for the Financial Year 2026-27.
- Standalone total income for FY26 was INR Lakhs 35,159.71, down from INR Lakhs 41,018.11 in FY25.
- Standalone profit/(loss) before tax for FY26 was INR Lakhs (1,340.10), compared to INR Lakhs 3,376.36 in FY25.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Net) FY26
INR Lakhs 34,223.55
Standalone Revenue from Operations (Net) FY25
INR Lakhs 40,551.16
Standalone Profit/(Loss) before tax FY26
INR Lakhs (1,340.10)
Standalone Profit/(Loss) before tax FY25
INR Lakhs 3,376.36
Final Dividend per equity share FY26
Re. 0.50
Total Final Dividend amount FY26
Rs. 4,60,50,060
🏢 How This Affects the Company
The decline in revenue from operations for the financial year ended March 31, 2026, indicates a contraction in sales compared to the previous year.
The company reported a standalone loss before tax for FY26, a significant shift from the profit reported in FY25, impacting overall earnings.
The reported standalone loss before tax for FY26, alongside a decrease in revenue, indicates a heightened financial risk compared to the previous fiscal year.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must approve the recommended final dividend of Re. 0.50 per equity share at the forthcoming Annual General Meeting.
👤
Who Is Affected
All equity shareholders will be affected by the proposed final dividend of Re. 0.50 per equity share, aggregating Rs. 4,60,50,060.
🔍
Management Signal
The management's recommendation of a final dividend despite reporting a net loss indicates a commitment to regular shareholder distributions, subject to approval.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Annual General Meeting date — for dividend approval and other resolutions.
Consolidated financial results — for overall group performance analysis.
Next quarter's results — to observe revenue and profitability trends.
MEDIUM RISK
The company reported a significant standalone loss before tax for FY26, a reversal from the previous year's profit.
💡 Investor Takeaway
Themis Medicare Ltd. reported a standalone net loss before tax of INR Lakhs (1,340.10) for the year ended March 31, 2026, compared to a profit of INR Lakhs 3,376.36 in FY25. Revenue from operations for FY26 decreased to INR Lakhs 34,223.55. A final dividend of Re. 0.50 per equity share was recommended.
⚖️ Strengths & Concerns
✅ Positives
- Recommendation of a final dividend of Re. 0.50 per equity share for FY26, demonstrating commitment to shareholder returns.
- Re-appointment of M/s. R. Nanabhoy & Co. as Cost Auditor ensures continuity in cost management oversight for FY27.
⚠️ Concerns
- Standalone Revenue from Operations (Net) for FY26 decreased to INR Lakhs 34,223.55 from INR Lakhs 40,551.16 in FY25.
- Standalone Profit/(Loss) before tax for FY26 was INR Lakhs (1,340.10), a decline from INR Lakhs 3,376.36 in FY25.
❓ Frequently Asked Questions
What were Themis Medicare Ltd.'s standalone revenues for the year ended March 31, 2026?
Themis Medicare Ltd.'s standalone Revenue from Operations (Net) for the year ended March 31, 2026, was INR Lakhs 34,223.55.
What was Themis Medicare Ltd.'s standalone profit before tax for FY26?
Themis Medicare Ltd.'s standalone Profit/(Loss) before tax for the year ended March 31, 2026, was INR Lakhs (1,340.10).
What dividend did Themis Medicare Ltd. recommend for the Financial Year 2026?
Themis Medicare Ltd. recommended a final dividend of Re. 0.50 per equity share for the Financial Year ended March 31, 2026, aggregating to Rs. 4,60,50,060.
Who was appointed as the Cost Auditor for Themis Medicare Ltd. for FY2026-27?
M/s. R. Nanabhoy & Co., Cost Accountants (FRN - 000011), was re-appointed as the Cost Auditor for Themis Medicare Ltd. for the Financial Year 2026-27.
Questions based on this BSE filing only. For information purposes.